Approval of the Pfizer/BioNTech vaccine Timelines: Covid-updates

Approval of the Pfizer/BioNTech vaccine Timelines: Covid-updates

Following approval of the Pfizer/BioNTech vaccine for use in the UK last week, the NHS has begun phase one of a national vaccination programme, which aims to immunise 40% of the UK population. At the moment, the Pfizer/BioNTech vaccine is the only vaccination approved for use in the UK and it is not available outside of the central NHS distribution programme. Due to storage requirements and current batch size, the programme is being delivered from a limited number of hospital hubs across the UK, prioritising older people and those who are classed as vulnerable.